author-photo

Anthony B. El-Khoueiry

University of Southern California

328

Papers

8092

Citations

Citation Trend

Filter By

Papers (328) Sort By

JournalConferenceOthers

P-70 First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Cabozantinib: An Evolving Therapy for Hepatocellular Carcinoma

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (3)
Initial findings of the first-in-human phase I study of AGEN2373, a conditionally active CD137 agonist antibody, in patients (pts) with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
501 Survival and immune response data from intratumoral INT230–6 alone (IT-01) and with pembrolizumab [KEYNOTE-A10] in subjects with locally advanced, unresectable and metastatic solid tumors

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Early results of intratumoral INT230-6 alone or in combination with ipilimumab in subjects with advanced sarcomas.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of Cabozantinib for Patients with Advanced Hepatocellular Carcinoma and Child-Pugh B Liver Function: Retrospective Analysis From the CELESTIAL Randomised Controlled Trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis

2021 Liver cancer
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号